BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kapoor N, Audsley J, Rupali P, Sasadeusz J, Paul TV, Thomas N, Lewin SR. A gathering storm: HIV infection and nonalcoholic fatty liver disease in low and middle-income countries. AIDS 2019;33:1105-15. [PMID: 31045941 DOI: 10.1097/QAD.0000000000002161] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Rose PC, De la Rey Nel E, Cotton MF, Otwombe K, Browne SH, Frigati LJ, Rabie H, Innes S. Decreased Hepatic Steatosis in South African Adolescents With Perinatal HIV Switching to Dolutegravir-containing Regimens. Pediatr Infect Dis J 2023. [PMID: 36917035 DOI: 10.1097/INF.0000000000003904] [Reference Citation Analysis]
2 Schwarz C, Chromy D, Bauer D, Duong N, Schmidbauer VU, Schwarz M, Mandorfer M, Rieger A, Trauner M, Gschwantler M, Reiberger T. Prevalence and dynamics of NAFLD-associated fibrosis in people living with HIV in Vienna from first presentation to last follow-up. Wien Klin Wochenschr 2022. [PMID: 36576556 DOI: 10.1007/s00508-022-02133-9] [Reference Citation Analysis]
3 Kapoor N, Kalra S, Al Mahmeed W, Al-Rasadi K, Al-Alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Firenze A, Galia M, Goh SY, Janez A, Kempler P, Lessan N, Lotufo P, Papanas N, Rizvi AA, Sahebkar A, Santos RD, Stoian AP, Toth PP, Viswanathan V, Rizzo M; CArdiometabolic Panel of International experts on Syndemic COvid-19 (CAPISCO). The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact. Diabetes Ther 2022;13:1723-36. [PMID: 36030317 DOI: 10.1007/s13300-022-01311-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Qian Z, Wu H, Wu Y, Liao W, Yu T, Xu X, Peng J, Cai S. A model for predicting high BMI of people living with HIV after receiving antiretroviral therapy. Ther Adv Chronic Dis 2022;13:20406223221102750. [PMID: 35757780 DOI: 10.1177/20406223221102750] [Reference Citation Analysis]
5 Martinez MA, Tural C, Franco S. Circulating MicroRNAs as a Tool for Diagnosis of Liver Disease Progression in People Living with HIV-1. Viruses 2022;14:1118. [DOI: 10.3390/v14061118] [Reference Citation Analysis]
6 Carrasco I, Olveira A, Lancharro Á, Escosa L, Mellado MJ, Busca C, Montes ML, Díez C, Alcolea-Ruiz S, Navarro ML, Sainz T. Prevalence of nonalcoholic fatty liver disease using noninvasive techniques among children, adolescents, and youths living with HIV. AIDS 2022;36:805-14. [PMID: 35013082 DOI: 10.1097/QAD.0000000000003170] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Rose PC, Nel ED, Cotton MF, Pitcher RD, Otwombe K, Browne SH, Innes S. Prevalence and Risk Factors for Hepatic Steatosis in Children With Perinatal HIV on Early Antiretroviral Therapy Compared to HIV-Exposed Uninfected and HIV-Unexposed Children. Front Pediatr 2022;10:893579. [PMID: 35757117 DOI: 10.3389/fped.2022.893579] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Rossetti B, Borgo V, Emiliozzi A, Colaneri M, Zanelli G, d’Alessandro M, Motta D, Maiocchi L, Montagnani F, Moioli MC, Baiguera C, Sambo M, Pieri TC, Valsecchi P, Bruno R, Puoti M, Fabbiani M. Discordant Liver Fibrosis Predictors in Virologically Suppressed People Living with HIV without Hepatitis Virus Infection. Diagnostics 2021;12:14. [DOI: 10.3390/diagnostics12010014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Debroy P, Nagraj S, Chamorro-pareja N, Castro N, de Leon A, Guerson-gil A, Quintero O, Laniado I, Kladas M, Desai D, Mathias P, Leider J, Kishore P, Palaiodimos L, Kotler DP. Assessment of the Association of HIV Infection with Hepatic Steatosis or Fibrosis: a Cross-sectional Case–Control Study. SN Compr Clin Med 2021;3:2504-2510. [DOI: 10.1007/s42399-021-01054-4] [Reference Citation Analysis]
10 Bakasis AD, Androutsakos T. Liver Fibrosis during Antiretroviral Treatment in HIV-Infected Individuals. Truth or Tale? Cells 2021;10:1212. [PMID: 34063534 DOI: 10.3390/cells10051212] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
11 Cooper C, Driedger M, Wong D, Haylock-Jacobs S, Aziz Shaheen A, Osiowy C, Fung S, Doucette K, Wong A, Barrett L, Conway B, Ramji A, Minuk G, Sebastiani G, Wong P, Coffin CS. Distinct Hepatitis B and HIV co-infected populations in Canada. J Viral Hepat 2021;28:517-27. [PMID: 33306853 DOI: 10.1111/jvh.13453] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
12 Dinani A, Khan A, Dieterich D. Emerging prevalence of fatty liver disease in HIV. Future Virology 2021;16:59-73. [DOI: 10.2217/fvl-2020-0184] [Reference Citation Analysis]
13 Atri A, Jiwanmall SA, Nandyal MB, Kattula D, Paravathareddy S, Paul TV, Thomas N, Kapoor N. The Prevalence and Predictors of Non-alcoholic Fatty Liver Disease in Morbidly Obese Women - A Cross-sectional Study from Southern India.Eur Endocrinol. 2020;16:152-155. [PMID: 33117448 DOI: 10.17925/EE.2020.16.2.152] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
14 Kapoor N, Lotfaliany M, Sathish T, Thankappan KR, Thomas N, Furler J, Oldenburg B, Tapp RJ. Obesity indicators that best predict type 2 diabetes in an Indian population: insights from the Kerala Diabetes Prevention Program. J Nutr Sci 2020;9:e15. [PMID: 32328239 DOI: 10.1017/jns.2020.8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]